CAJ | 학술논문

目的：评价丹蛭降糖胶囊对2型糖尿病患者 FINS 和 IRI 作用的有效性。方法：计算机检索中国生物医学文献数据库、中国期刊全文数据库、万方期刊数据库等相关资料，按照 Cochrane 系统评价的方法，客观评价纳入研究的质量，提取有效数据，采用 RevMan 5.2软件进行 Meta 分析。结果：共纳入5个随机对照试验，包括294例患者。结果显示，丹蛭降糖胶囊能降低2型糖尿病患者 FINS[MD ＝1.24，95％ CI（0.90，1.59），P ＜0.01]，降低 IRI[MD ＝0.20，95％ CI（0.14，0.27），P ＜0.01]。结论：丹蛭降糖胶囊对2型糖尿病患者 FINS 和 IRI 作用是有效的。
목적：평개단질강당효낭대2형당뇨병환자 FINS 화 IRI 작용적유효성。방법：계산궤검색중국생물의학문헌수거고、중국기간전문수거고、만방기간수거고등상관자료，안조 Cochrane 계통평개적방법，객관평개납입연구적질량，제취유효수거，채용 RevMan 5.2연건진행 Meta 분석。결과：공납입5개수궤대조시험，포괄294례환자。결과현시，단질강당효낭능강저2형당뇨병환자 FINS[MD ＝1.24，95％ CI（0.90，1.59），P ＜0.01]，강저 IRI[MD ＝0.20，95％ CI（0.14，0.27），P ＜0.01]。결론：단질강당효낭대2형당뇨병환자 FINS 화 IRI 작용시유효적。
Objective:To evaluate the efficacy of Danzhijiangtang Capsule on FINS and IRI of patients with type 2 diabetes mellitus. Methods:Randomized controlled trials were electronically retrieved from CBM,CNKI,Wanfang Database,and so on.All articles were as-sessed according to the Cochrane Handbook for Systematic Reviews of interventions and then effective data were analyzed by RevMan 5. 2 soft ware.Results:Five randomized controlled trials involving 294 Patients were included.Results of Meta-analysis showed that there was statistical difference in the Fasting Insul in [MD =1.24,95% CI(0.90,1.59),P <0.01],Insulin Resistance Index[MD =0. 20,95% CI(0.14,0.27),P <0.01.Conclusion:Danzhijiangtang capsule is effective for FINS and IRI of patients with type 2 diabetes.